Department of Pathology Johns Hopkins Barrett's Esophagus Homepage Barrett's Esophagus Appointments Barrett's Esophagus Second Opinions Barrett's Esophagus Glossary Barretts Esophagus Resources Barrett's Esophagus Giving
Barrett's Esophagus  
Understanding Barrett's EsophagusBarrett's Esophagus Research at Johns Hopkins UniversityBarretts Esophagus: What's NewDiscuss Barrett's EsophagusClinical TrialsFundraising
    

Related Web Sites

Related Publications

 
 
Related Johns Hopkins Publications
Recent Publications | Previous Publications
Recent Publications
  1. Brock MV, Gou M, Akiyama Y, Muller A, Wu TT, Montgomery E, Deasel M, Germonpre P, Rubinson L, Heitmiller RF, Yang SC, Forastiere AA, Baylin SB, Herman JG: Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res 2003, 9:2912-2919.

  2. Canto MI: Barrett's esophagus and early esophageal cancer. Gastrointest Endosc 2002, 56:S66-68.

  3. Canto MI: Barrett's esophagus. Gastrointest Endosc Clin N Am 2005, 15:83-92, ix

  4. Canto MI: Chromoendoscopy and magnifying endoscopy for Barrett's esophagus. Clin Gastroenterol Hepatol 2005, 3:S12-15.

  5. Canto MI, Yoshida T, Gossner L: Chromoscopy of intestinal metaplasia in Barrett's esophagus. Endoscopy 2002, 34:330-336.

  6. Forastiere A: The role of chemotherapy in the treatment of esophageal cancer. Clin Adv Hematol Oncol 2005, 3:254-256

  7. Gibson MK, Abraham SC, Wu TT, Burtness B, Heitmiller RF, Heath E, Forastiere A: Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy. Clin Cancer Res 2003, 9:6461-6468

  8. Gibson MK, Forastiere AA: Combined-modality therapy for esophageal cancer: are we making progress? Cancer J 2003, 9:238-240

  9. Hansel DE, Dhara S, Huang RC, Ashfaq R, Deasel M, Shimada Y, Bernstein HS, Harmon J, Brock M, Forastiere A, Washington MK, Maitra A, Montgomery E: CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. Am J Surg Pathol 2005, 29:390-399

  10. Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, Maitra A: Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol 2004, 28:347-356

  11. Heath EI, Canto MI, Wu TT, Piantadosi S, Hawk E, Unalp A, Gordon G, Forastiere AA: Chemoprevention for Barrett's esophagus trial. Design and outcome measures. Dis Esophagus 2003, 16:177-186

  12. Heath EI, Kaufman HS, Talamini MA, Wu TT, Wheeler J, Heitmiller RF, Kleinberg L, Yang SC, Olukayode K, Forastiere AA: The role of laparoscopy in preoperative staging of esophageal cancer. Surg Endosc 2000, 14:495-499

  13. Heath EI, Limburg PJ, Hawk ET, Forastiere AA: Adenocarcinoma of the esophagus: risk factors and prevention. Oncology (Williston Park) 2000, 14:507-514; discussion 518-520, 522-503

  14. Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA: Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2003, 56:328-334

  15. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, Ronnett BM, De Marzo AM: Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 2004, 10:3317-3326

  16. Montgomery E: Is there a way for pathologists to decrease interobserver variability in the diagnosis of dysplasia? Arch Pathol Lab Med 2005, 129:174-176

  17. Powell EL, Leoni LM, Canto MI, Forastiere AA, Iocobuzio-Donahue CA, Wang JS, Maitra A, Montgomery E: Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications. Am J Surg Pathol 2005, 29:1497-1504

  18. Sui G, Bonde P, Dhara S, Broor A, Wang J, Marti G, Feldmann G, Duncan M, Montgomery E, Maitra A, Harmon JW: Epidermal Growth Factor Receptor and Hedgehog Signaling Pathways Are Active in Esophageal Cancer Cells From Rat Reflux Model. J Surg Res 2006

Recent Publications | Previous Publications
Previous Publications

    1. Canto, MI, Setrakian S, Willis J, Chak A, Petras R, Powe NR, Sivak MV, Jr. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus.Gastrointest Endosc 2000; 51: 560-8.

    2. Bhargava, P, Eisen GM, Holterman DA, Azumi N, Hartmann DP, Hanfelt JJ, Benjamin SB, Lippman ME, Montgomery EA. Endoscopic mapping and surrogate markers for better surveillance in Barrett esophagus. A study of 700 biopsy specimens [In Process Citation]. Am J Clin Pathol 2000; 114: 552-63.

    3. Montgomery, E, Goldblum JR, Greenson JK, Haber MM, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Zahurak ML, Hart J. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 2001; 32: 379-88.

    4. Montgomery, E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toledano AY, Shyr Y, Washington K. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001; 32: 368-78.

    5. Chak, A, Canto MI, Cooper GS, Isenberg G, Willis J, Levitan N, Clayman J, Forastiere A, Heath E, Sivak MV, Jr. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. Cancer 2000; 88: 1788-95.

    6. Canto, MI, Setrakian S, Willis JE, Chak A, Petras RE, Sivak MV. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study. Endoscopy 2001; 33: 391-400.

    7. Heath, EI, Forastiere AA. Therapy for esophageal cancer. Cancer Treat Res 2001; 105: 387-98.

    8. Urba, SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-13.

    9. Canto MI, Yoshida T, Gossner L: Chromoscopy of Intestinal Metaplasia in Barrett's Esophagus. Endoscopy 2002; 34:330-336.

    10. Gross CP, Cruz-Correa M, Canto MI, McNeil-Solis C, Valente TW, Powe NR: The adoption of ablation therapy for Barrett's esophagus: a cohort study of gastroenterologists. Am J Gastroenterol 2002; 97:279-286.

    11. Montgomery E, Bronner MP, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Goldblum JR: Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up.Am J Gastroenterol 2002; 97:27-31.
    12. Agha FP, Gennis MA, Orringer MB, Forastiere AA. Evaluation of response to preoperative chemotherapy in esophageal and gastric cardia cancer using biphasic esophagrams and surgical- pathologic correlation. Am J Clin Oncol. 1986;9:227-32.

    13. Heitmiller RF. The left thoracoabdominal incision. Ann Thorac Surg. 1988;46:250-3.

    14. Heitmiller RF. Thoracic incisions [letter]. Ann Thorac Surg. 1988;46:601. (no abstract available)

    15. Heitmiller RF. The serratus sling: a simplified serratus-sparing technique. Ann Thorac Surg. 1989;48:867-8.

    16. Heitmiller RF, Nikoomanesh P, Ravich WJ. Esophageal motility in an adult with a congenital H-type tracheoesophageal fistula. Dysphagia. 1990;5:138-41.

    17. Orringer MB, Forastiere AA, Perez-Tamayo C, Urba S, Takasugi BJ, Bromberg J. Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma [see comments]. Ann Thorac Surg. 1990;49:348-54; discussion 354-5.

    18. Forastiere AA, Orringer MB, Perez-Tamayo C et al. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol. 1990;8:119-27.

    19. Heitmiller RF. Surgical solutions for esophageal dysphagia. Dysphagia. 1991;6:79-82. (no abstract available)

    20. Kronthal AJ, Heitmiller RF, Fishman EK, Kuhlman JE. Mediastinal seroma after esophagogastrectomy. AJR Am J Roentgenol. 1991;156:715-6. (no abstract available)

    21. Heitmiller RF, Jones B. Transient diminished airway protection after transhiatal esophagectomy. Am J Surg. 1991;162:442-6.

    22. Heitmiller RF, Venbrux AC, Osterman FA. Percutaneous replacement jejunostomy. Ann Thorac Surg. 1992;53:711-3.

    23. Heitmiller RF. Results of standard left thoracoabdominal esophagogastrectomy. Semin Thorac Cardiovasc Surg. 1992;4:314-9.

    24. Fraser CD, Heitmiller RF. Cervical esophago-esophageal anastomosis [see comments]. Ann Thorac Surg. 1992;54:384-6.

    25. Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol. 1993;11:1118-23.

    26. Reichle RL, Fishman EK, Nixon MS, Heitmiller RF, Rubesin SE, Jones B. Evaluation of the postsurgical esophagus after partial esophagogastrectomy for esophageal cancer. Normal postoperative appearance and complications. Invest Radiol. 1993;28:247-57 (no abstract available).

    27. Stone CD, Heitmiller RF. Simplified, standardized technique for cervical esophagogastric anastomosis. Ann Thorac Surg. 1994;58:259-61.

    28. Cheng W, Heitmiller RF, Jones B. Subacute ischemia of the colon esophageal interposition. Ann Thorac Surg. 1994;57:899-903.

    29. O'Reilly S, Forastiere A. New approaches to treating oesophageal cancer [editorial] [see comments]. Bmj. 1994;308:1249-50.

    30. Reichle RL, Venbrux AC, Heitmiller RF, Osterman FA. Percutaneous jejunostomy replacement in patients who have undergone esophagectomy. J Vasc Interv Radiol. 1995;6:939-42.

    31. Noh HM, Fishman EK, Forastiere AA, Bliss DF, Calhoun PS. CT of the esophagus: spectrum of disease with emphasis on esophageal carcinoma. Radiographics. 1995;15:1113-34.

    32. Liu M, Rock P, Grass JA et al. Double-blind randomized evaluation of intercostal nerve blocks as an adjuvant to subarachnoid administered morphine for post-thoracotomy analgesia. Reg Anesth. 1995;20:418-25.

    33. Chak A, Canto M, Gerdes H et al. Prognosis of esophageal cancers preoperatively staged to be locally invasive (T4) by endoscopic ultrasound (EUS): a multicenter retrospective cohort study. Gastrointest Endosc. 1995;42:501-6.

    34. Flood WA, Forastiere AA. Esophageal cancer. Curr Opin Oncol. 1995;7:381-6.

    35. O'Reilly S, Forastiere AA. Is surgery necessary with multimodality treatment of oesophageal cancer [editorial; comment]. Ann Oncol. 1995;6:519-21.

    36. Heitmiller RF. Tracheal release maneuvers. Chest Surg Clin N Am. 1996;6:675-82.

    37. Canto MI, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV, Jr. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc. 1996;44:1-7.

    38. Davis EA, Heitmiller RF. Esophagectomy for benign disease: trends in surgical results and management. Ann Thorac Surg. 1996;62:369-72.

    39. Moskaluk CA, Heitmiller R, Zahurak M, Schwab D, Sidransky D, Hamilton SR. p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction. Hum Pathol. 1996;27:1211-20.

    40. Montgomery EA, Hartmann DP, Carr NJ, Holterman DA, Sobin LH, Azumi N. Barrett esophagus with dysplasia. Flow cytometric DNA analysis of routine, paraffin-embedded mucosal biopsies. Am J Clin Pathol. 1996;106:298-304.

    41. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg. 1996;224:66-71.

    42. Heitmiller RF, Sharma RR. Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma. J Thorac Cardiovasc Surg. 1996;112:130-6.

    43. Chak A, Canto MI, Rosch T et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc. 1997;45:468-73.

    44. Forastiere AA, Heitmiller RF, Kleinberg L. Multimodality therapy for esophageal cancer. Chest. 1997;112:195S-200S.

    45. Heitmiller RF, Gillinov AM, Jones B. Transhiatal herniation of colon after esophagectomy and gastric pull-up. Ann Thorac Surg. 1997;63:554-6.

    46. Heitmiller RF, Gillinov AM, Kafonek D. Transthoracic percutaneous endoscopic gastrostomy (PEG) after esophagectomy and gastric pull-up. Surg Laparosc Endosc 1997 Aug;7(4):351-3.

    47. Phan GQ, Heitmiller RF. Intramural esophageal dissection. Ann Thorac Surg. 1997;63:1785-6.

    48. Kelsen D, Ginsberg R, Bains M et al. A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report. Semin Oncol. 1997;24:S19-77-S19-81.

    49. Forastiere AA, Heitmiller RF, Lee DJ et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus [see comments]. Cancer J Sci Am. 1997;3:144-52.

    50. Chak A, Canto M, Stevens PD et al. Clinical applications of a new through-the-scope ultrasound probe: prospective comparison with an ultrasound endoscope. Gastrointest Endosc. 1997;45:291-5.

    51. Chak A, Soweid A, Hoffman B et al. Clinical implications of endoluminal ultrasonography using through-the- scope catheter probes [see comments]. Gastrointest Endosc. 1998;48:485-90.

    52. Flood WA, Forastiere AA. Esophageal cancer. Cancer Treat Res. 1998;98:1-40.

    53. Ilson DH, Ajani J, Bhalla K et al. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol. 1998;16:1826-34.

    54. Salazar JD, Doty JR, Lin JW, Dyke MC, Roberts J, Heitmiller ES, Heitmiller RF. Does cell type influence post-esophagectomy survival in patients with esophageal cancer? Dis Esophagus 1998 Jul;11(3):168-71.

    55. Isenberg G, Chak A, Canto MI et al. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation. Gastrointest Endosc. 1998;48:158-63.

    56. Wu TT, Watanabe T, Heitmiller R, Zahurak M, Forastiere AA, Hamilton SR. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol. 1998;153:287-94.

    57. Chak A, Soweid A, Hoffman B et al. Clinical implications of catheter probe-assisted endoluminal ultrasonography. Endoscopy. 1998;30 Suppl 1:A169-72.

    58. Gross CP, Canto MI, Hixson J, Powe NR. Management of Barrett's esophagus: a national study of practice patterns and their cost implications [In Process Citation]. Am J Gastroenterol. 1999;94:3440-7.

    59. Canto MI. Vital staining and Barrett's esophagus. Gastrointest Endosc. 1999;49:S12-6.

    60. Forastiere AA, Trotti A. Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer [editorial; comment]. J Natl Cancer Inst. 1999;91:2065-6.

    61. Eisen GM, Montgomery EA, Azumi N et al. Qualitative mapping of Barrett's metaplasia: a prerequisite for intervention trials [In Process Citation]. Gastrointest Endosc. 1999;50:814-8.

    62. Canto MI. Staining in gastrointestinal endoscopy: the basics. Endoscopy. 1999;31:479-86.

    63. Heath EI, Holbrook JT, Forastiere AA. Gastroesophageal reflux and adenocarcinoma of the esophagus [letter]. N Engl J Med. 1999;341:536-7; discussion 537-8.

    64. Heitmiller RF, Fischer A, Liddicoat JR. Cervical esophagogastric anastomosis: results following esophagectomy for carcinoma. Dis Esophagus 1999;12(4):264-9.

    65. Heath EI, Kaufman HS, Talamini MA, Wu TT, Wheeler J, Heitmiller RF, Kleinberg L, Yang SC, Olukayode K, Forastiere AA. The role of laparoscopy in preoperative staging of esophageal cancer. Surg Endosc 2000 May;14(5):495-9.

    66. Heitmiller RF, Forastiere AA, Kleinberg L, Zahurak M. Neoadjuvant chemoradiation followed by surgery for resectable esophageal cancer. Cancer Res 2000;155:97-104.

    67. Heath EI, Burtness BA, Heitmiller RF, Salem R, Kleinberg L, Knisely JP, Yang SC, Talamini MA, Kaufman HS, Canto MI, Topazian M, Wu TT, Olukayode K, Forastiere AA. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000 Feb;18(4):868-76.

    68. Brock MV, Venbrux AC, Heitmiller RF. Percutaneous replacement jejunostomy after esophagogastrectomy. J Gastrointest Surg 2000 Jul;4(4):407-10.

    69. Stone CD, Heitmiller RF. As originally published in 1994: Simplified, standardized technique for cervical esophagogastric anastomosis. Updated in 2000. Ann Thorac Surg 2000 Sep;70(3):999-1000.
 
  
  
Copyright © 2000-2009 Johns Hopkins University. All rights reserved. Feedback | Disclaimer